J Pediatr Genet 2013; 02(04): 173-180
DOI: 10.3233/PGE-13066
Georg Thieme Verlag KG Stuttgart – New York

Clinical findings in children with congenital anomalies and misoprostol intrauterine exposure: a study of 38 cases

Siulan Vendramini-Pittoli
a   Department of Clinical Genetics, Hospital of Rehabilitation of Craniofacial Anomalies (HRCA), University of São Paulo, Bauru, SP, Brazil
,
Maria L. Guion-Almeida
a   Department of Clinical Genetics, Hospital of Rehabilitation of Craniofacial Anomalies (HRCA), University of São Paulo, Bauru, SP, Brazil
,
Antonio Richieri-Costa
a   Department of Clinical Genetics, Hospital of Rehabilitation of Craniofacial Anomalies (HRCA), University of São Paulo, Bauru, SP, Brazil
,
Juliana M. Santos
b   Program of Postgraduate in Science of Rehabilitation, Hospital of Rehabilitation of Craniofacial Anomalies, University of São Paulo, Bauru, SP, Brazil
,
Nancy M. Kokitsu-Nakata
a   Department of Clinical Genetics, Hospital of Rehabilitation of Craniofacial Anomalies (HRCA), University of São Paulo, Bauru, SP, Brazil
› Author Affiliations

Subject Editor:
Further Information

Publication History

13 September 2013

26 January 2014

Publication Date:
27 July 2015 (online)

Abstract

The authors describe the clinical findings of 38 children with congenital anomalies and misoprostol intrauterine exposure. This study included 38 cases, ascertained from case series of the Hospital of Rehabilitation of Craniofacial Anomalies from University of São Paulo, with evidence of intrauterine exposure to misoprostol in the first trimester of the pregnancy. Information about misoprostol intake and drug administration route was obtained through interviews with mothers. Clinical evaluation showed 18 individuals with facial phenotype compatible with Moebius syndrome; 11 individuals with multiple congenital anomalies; and nine individuals with nonsyndromic cleft lip and/or cleft palate. This study showed a widening of the phenotypic spectrum associated with misoprostol embryotoxicity.